Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endometrial Neoplasms | 6 | 2023 | 1353 | 0.930 |
Why?
|
Sex Reassignment Surgery | 1 | 2023 | 130 | 0.750 |
Why?
|
DNA Mismatch Repair | 2 | 2022 | 426 | 0.670 |
Why?
|
Brachytherapy | 4 | 2022 | 1248 | 0.670 |
Why?
|
Rectal Neoplasms | 2 | 2014 | 1206 | 0.490 |
Why?
|
Nose Neoplasms | 1 | 2016 | 246 | 0.460 |
Why?
|
Fat Necrosis | 1 | 2013 | 58 | 0.460 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2022 | 2020 | 0.430 |
Why?
|
Neoplasm Staging | 13 | 2023 | 11031 | 0.370 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2022 | 9239 | 0.330 |
Why?
|
Adenocarcinoma | 4 | 2014 | 6364 | 0.310 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2014 | 2043 | 0.310 |
Why?
|
Vagina | 2 | 2023 | 825 | 0.300 |
Why?
|
Urinalysis | 1 | 2009 | 369 | 0.290 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2013 | 1381 | 0.260 |
Why?
|
Colonic Neoplasms | 2 | 2014 | 2541 | 0.260 |
Why?
|
Lymph Nodes | 5 | 2023 | 3474 | 0.260 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4186 | 0.250 |
Why?
|
Metabolic Networks and Pathways | 1 | 2009 | 783 | 0.250 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2020 | 4034 | 0.250 |
Why?
|
Breast | 1 | 2013 | 1969 | 0.240 |
Why?
|
Hysterectomy | 2 | 2020 | 927 | 0.220 |
Why?
|
Adenomatous Polyposis Coli Protein | 2 | 2014 | 188 | 0.220 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2728 | 0.220 |
Why?
|
GTP Phosphohydrolases | 3 | 2014 | 509 | 0.210 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4554 | 0.200 |
Why?
|
Anal Canal | 1 | 2023 | 376 | 0.180 |
Why?
|
Radiotherapy Dosage | 3 | 2016 | 2879 | 0.170 |
Why?
|
Lymph Node Excision | 2 | 2022 | 1261 | 0.170 |
Why?
|
Age Factors | 3 | 2013 | 18370 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 6 | 2021 | 6538 | 0.170 |
Why?
|
Enzyme Inhibitors | 2 | 2009 | 3798 | 0.160 |
Why?
|
Glioblastoma | 2 | 2015 | 3481 | 0.160 |
Why?
|
Prostatic Neoplasms | 2 | 2012 | 11124 | 0.160 |
Why?
|
Carcinoma, Endometrioid | 1 | 2020 | 271 | 0.160 |
Why?
|
Vulvar Neoplasms | 1 | 2020 | 272 | 0.150 |
Why?
|
Carcinoma, Adenosquamous | 1 | 2017 | 68 | 0.150 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2023 | 3479 | 0.150 |
Why?
|
Smoking | 3 | 2016 | 8987 | 0.140 |
Why?
|
Proportional Hazards Models | 4 | 2016 | 12354 | 0.140 |
Why?
|
Gene Amplification | 1 | 2020 | 1063 | 0.140 |
Why?
|
Karnofsky Performance Status | 1 | 2016 | 173 | 0.140 |
Why?
|
Lymphatic Irradiation | 1 | 2016 | 103 | 0.130 |
Why?
|
Female | 26 | 2023 | 380194 | 0.130 |
Why?
|
Retrospective Studies | 12 | 2023 | 77449 | 0.130 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2021 | 1770 | 0.130 |
Why?
|
DNA Methylation | 3 | 2014 | 4286 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2015 | 2948 | 0.130 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2017 | 255 | 0.130 |
Why?
|
Brain Neoplasms | 3 | 2015 | 8863 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11524 | 0.120 |
Why?
|
Cecal Neoplasms | 1 | 2014 | 29 | 0.120 |
Why?
|
Relative Biological Effectiveness | 1 | 2016 | 323 | 0.120 |
Why?
|
Community Health Centers | 1 | 2017 | 430 | 0.120 |
Why?
|
Neoplasms | 1 | 2023 | 21683 | 0.120 |
Why?
|
Radiotherapy | 2 | 2013 | 1533 | 0.120 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2016 | 234 | 0.120 |
Why?
|
Colon, Sigmoid | 1 | 2014 | 120 | 0.120 |
Why?
|
Aged | 15 | 2022 | 163280 | 0.110 |
Why?
|
Middle Aged | 17 | 2022 | 213383 | 0.110 |
Why?
|
Pelvis | 1 | 2017 | 730 | 0.110 |
Why?
|
Disease-Free Survival | 3 | 2021 | 6895 | 0.110 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2014 | 890 | 0.110 |
Why?
|
Mutation | 2 | 2015 | 29786 | 0.110 |
Why?
|
Tumor Burden | 3 | 2015 | 1915 | 0.110 |
Why?
|
Humans | 32 | 2023 | 744343 | 0.110 |
Why?
|
Survival Rate | 3 | 2017 | 12788 | 0.110 |
Why?
|
Breast Neoplasms | 4 | 2015 | 20822 | 0.110 |
Why?
|
Aged, 80 and over | 8 | 2016 | 57776 | 0.100 |
Why?
|
Organs at Risk | 1 | 2014 | 346 | 0.100 |
Why?
|
Radiography | 2 | 2013 | 7023 | 0.100 |
Why?
|
ras Proteins | 2 | 2014 | 1060 | 0.100 |
Why?
|
Mastectomy, Segmental | 2 | 2015 | 956 | 0.100 |
Why?
|
Radiation Oncology | 1 | 2017 | 555 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2020 | 578 | 0.100 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1333 | 0.100 |
Why?
|
Microsatellite Instability | 1 | 2014 | 684 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1583 | 0.090 |
Why?
|
Carcinoma, Lobular | 1 | 2015 | 484 | 0.090 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2013 | 233 | 0.090 |
Why?
|
Deoxycytidine | 1 | 2014 | 826 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2022 | 9648 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 1692 | 0.090 |
Why?
|
Organophosphorus Compounds | 1 | 2010 | 215 | 0.090 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2005 | 5221 | 0.090 |
Why?
|
Membrane Proteins | 4 | 2014 | 7880 | 0.090 |
Why?
|
Adult | 13 | 2020 | 214055 | 0.080 |
Why?
|
Comet Assay | 1 | 2009 | 71 | 0.080 |
Why?
|
Rectum | 1 | 2014 | 904 | 0.080 |
Why?
|
Fluorouracil | 1 | 2014 | 1619 | 0.080 |
Why?
|
Lymphoma, Follicular | 1 | 2013 | 435 | 0.080 |
Why?
|
Genital Neoplasms, Female | 1 | 2014 | 523 | 0.080 |
Why?
|
Bone Marrow Diseases | 1 | 2010 | 231 | 0.080 |
Why?
|
Male | 15 | 2023 | 350118 | 0.080 |
Why?
|
Neoplasm, Residual | 1 | 2013 | 973 | 0.080 |
Why?
|
Radiation Injuries | 1 | 2016 | 1180 | 0.080 |
Why?
|
Receptors, Growth Factor | 1 | 2009 | 334 | 0.080 |
Why?
|
Urinary Bladder | 1 | 2014 | 1172 | 0.080 |
Why?
|
Electric Countershock | 1 | 2010 | 534 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2014 | 2938 | 0.070 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2009 | 440 | 0.070 |
Why?
|
Treatment Failure | 1 | 2013 | 2618 | 0.070 |
Why?
|
Physical Examination | 1 | 2013 | 1237 | 0.070 |
Why?
|
Organometallic Compounds | 1 | 2010 | 665 | 0.070 |
Why?
|
Genotype | 4 | 2015 | 12951 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2014 | 5867 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 1941 | 0.070 |
Why?
|
Edema | 1 | 2010 | 789 | 0.070 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2009 | 520 | 0.070 |
Why?
|
Hydroxamic Acids | 1 | 2009 | 494 | 0.070 |
Why?
|
Colonoscopy | 1 | 2014 | 1367 | 0.070 |
Why?
|
Prognosis | 4 | 2020 | 29063 | 0.070 |
Why?
|
Dacarbazine | 1 | 2009 | 566 | 0.070 |
Why?
|
Age of Onset | 1 | 2012 | 3271 | 0.070 |
Why?
|
Smad8 Protein | 1 | 2005 | 17 | 0.070 |
Why?
|
Glutathione S-Transferase pi | 1 | 2005 | 97 | 0.060 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 1 | 2005 | 85 | 0.060 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2010 | 685 | 0.060 |
Why?
|
Alprostadil | 1 | 2004 | 89 | 0.060 |
Why?
|
Bronchi | 2 | 2005 | 840 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2014 | 8428 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2005 | 13102 | 0.060 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2005 | 494 | 0.060 |
Why?
|
Mitosis | 1 | 2009 | 1208 | 0.060 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2005 | 265 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2916 | 0.060 |
Why?
|
Isoenzymes | 2 | 2005 | 1726 | 0.060 |
Why?
|
Adenoma | 1 | 2014 | 2174 | 0.060 |
Why?
|
Glutathione Transferase | 1 | 2005 | 595 | 0.050 |
Why?
|
Chromosomes, Human | 1 | 2005 | 457 | 0.050 |
Why?
|
DNA, Neoplasm | 2 | 2005 | 1758 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6459 | 0.050 |
Why?
|
Prostate-Specific Antigen | 1 | 2012 | 2494 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2005 | 684 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3870 | 0.050 |
Why?
|
Cause of Death | 1 | 2012 | 3584 | 0.050 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2005 | 705 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2022 | 63114 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 1596 | 0.050 |
Why?
|
Respiratory Mucosa | 1 | 2005 | 427 | 0.050 |
Why?
|
ROC Curve | 1 | 2009 | 3527 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39050 | 0.050 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6314 | 0.050 |
Why?
|
Defibrillators, Implantable | 1 | 2010 | 1440 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2009 | 3557 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9438 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2005 | 849 | 0.050 |
Why?
|
Cadherins | 1 | 2005 | 907 | 0.050 |
Why?
|
Ultrasonography | 1 | 2013 | 5985 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3616 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2005 | 1072 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1157 | 0.040 |
Why?
|
DNA Repair | 1 | 2009 | 2046 | 0.040 |
Why?
|
Risk Factors | 4 | 2015 | 72290 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5853 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2009 | 4851 | 0.040 |
Why?
|
Esophagogastric Junction | 1 | 2020 | 313 | 0.040 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2529 | 0.040 |
Why?
|
Precancerous Conditions | 1 | 2005 | 975 | 0.040 |
Why?
|
Endometrium | 1 | 2020 | 424 | 0.040 |
Why?
|
Rh Isoimmunization | 1 | 2017 | 21 | 0.040 |
Why?
|
Heart Diseases | 1 | 2010 | 2788 | 0.040 |
Why?
|
Reperfusion Injury | 1 | 2004 | 1026 | 0.040 |
Why?
|
Salpingectomy | 1 | 2017 | 53 | 0.040 |
Why?
|
Combined Modality Therapy | 3 | 2017 | 8642 | 0.040 |
Why?
|
Quality of Life | 1 | 2017 | 12804 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2020 | 709 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12261 | 0.030 |
Why?
|
Apoptosis | 2 | 2009 | 9727 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2009 | 16689 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6171 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2924 | 0.030 |
Why?
|
Ovariectomy | 1 | 2017 | 661 | 0.030 |
Why?
|
Colon, Ascending | 1 | 2014 | 16 | 0.030 |
Why?
|
Cisplatin | 1 | 2020 | 1662 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2020 | 2649 | 0.030 |
Why?
|
Proteins | 1 | 2009 | 6103 | 0.030 |
Why?
|
Time Factors | 4 | 2021 | 40075 | 0.030 |
Why?
|
Young Adult | 3 | 2015 | 56430 | 0.030 |
Why?
|
MutS Homolog 2 Protein | 1 | 2014 | 200 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 496 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2009 | 10481 | 0.030 |
Why?
|
Retreatment | 1 | 2015 | 610 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 349 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2010 | 5751 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2005 | 4462 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 4456 | 0.030 |
Why?
|
Disease Progression | 2 | 2005 | 13284 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20129 | 0.020 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2014 | 379 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 2014 | 839 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 871 | 0.020 |
Why?
|
Mitotic Index | 1 | 2009 | 172 | 0.020 |
Why?
|
Adolescent | 2 | 2015 | 85781 | 0.020 |
Why?
|
Colonic Polyps | 1 | 2014 | 542 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1142 | 0.020 |
Why?
|
Cesarean Section | 1 | 2017 | 1365 | 0.020 |
Why?
|
Models, Biological | 1 | 2005 | 9583 | 0.020 |
Why?
|
Equipment Failure | 1 | 2010 | 578 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2593 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
Acetylation | 1 | 2009 | 1085 | 0.020 |
Why?
|
Schizophrenia | 1 | 2005 | 6882 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 35421 | 0.020 |
Why?
|
Immunoblotting | 1 | 2009 | 1682 | 0.020 |
Why?
|
Dermatoglyphics | 1 | 2005 | 21 | 0.020 |
Why?
|
Leg | 1 | 2010 | 1116 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23338 | 0.020 |
Why?
|
Mice | 2 | 2009 | 81183 | 0.020 |
Why?
|
Immunotherapy | 1 | 2020 | 4445 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2009 | 728 | 0.020 |
Why?
|
Cyclooxygenase 1 | 1 | 2004 | 104 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3508 | 0.010 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2009 | 789 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 329 | 0.010 |
Why?
|
Mice, Nude | 1 | 2009 | 3689 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 802 | 0.010 |
Why?
|
Equipment Design | 1 | 2010 | 3582 | 0.010 |
Why?
|
Leukocytes | 1 | 2010 | 2043 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2004 | 611 | 0.010 |
Why?
|
Dinoprostone | 1 | 2004 | 600 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 2005 | 733 | 0.010 |
Why?
|
Cell Cycle | 1 | 2009 | 2967 | 0.010 |
Why?
|
CpG Islands | 1 | 2005 | 1172 | 0.010 |
Why?
|
Bone Marrow | 1 | 2010 | 2948 | 0.010 |
Why?
|
Animals | 2 | 2009 | 168757 | 0.010 |
Why?
|
Blood Platelets | 1 | 2010 | 2508 | 0.010 |
Why?
|
Microcirculation | 1 | 2004 | 1286 | 0.010 |
Why?
|
Lactic Acid | 1 | 2004 | 1133 | 0.010 |
Why?
|
Histones | 1 | 2009 | 2599 | 0.010 |
Why?
|
Brain | 1 | 2005 | 26385 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
Pregnancy | 1 | 2017 | 29144 | 0.010 |
Why?
|
RNA | 1 | 2005 | 2749 | 0.010 |
Why?
|
Cell Survival | 1 | 2004 | 5882 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2010 | 9959 | 0.010 |
Why?
|
Alleles | 1 | 2005 | 6933 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4803 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 12797 | 0.010 |
Why?
|
Infant | 1 | 2015 | 35136 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3690 | 0.010 |
Why?
|
Child, Preschool | 1 | 2015 | 41006 | 0.010 |
Why?
|
Gene Expression | 1 | 2005 | 7799 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2005 | 18111 | 0.010 |
Why?
|
DNA | 1 | 2005 | 7301 | 0.010 |
Why?
|
Skin | 1 | 2004 | 4364 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 53288 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15997 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2004 | 13033 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2005 | 21746 | 0.000 |
Why?
|
Child | 1 | 2015 | 77709 | 0.000 |
Why?
|